X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

UK ushers in new foreign takeover restrictions for Coronavirus-critical businesses and national security activities

The UK government has tabled changes to the Enterprise Act 2002 to expand the circumstances in which...

Read More >

Rising Tides: MSHA Penalties Increase For 2020

No penalty is a good penalty, but many Department of Labor fines just got worse – including those t...

Read More >

NLRB Issues Employer-Friendly Decisions Heading into the New Year

During the term of the Obama-era National Labor Relations Board (NLRB), we saw longstanding employer...

Read More >

Antitrust Review of Mergers & Acquisitions in Light of COVID-19

Like other regulatory agencies and businesses, antitrust authorities around the globe are taking ste...

Read More >

PropTech Update - December 2020

Rent tech space bounces back in Q3 - Bullet GlobeSt.com – December 7 - After experiencing its w...

Read More >